Form 4: Macrogenics SVP, CFO, and Secretary James Karrels Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James Karrels, SVP, CFO, and Secretary of Macrogenics Inc., reports transactions involving common stock and derivative securities, including the vesting of restricted stock units and the grant of employee stock options.
Summary
- James Karrels, a senior officer at Macrogenics Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- The reported transactions include the vesting of 10,002 restricted stock units (RSUs) on February 8, 2025, which converted into common stock.
- Karrels also disposed of 3,861 shares of common stock at a price of $2.6, presumably to cover tax obligations related to the RSU vesting.
- Additionally, Karrels was granted 113,000 employee stock options on February 7, 2025, with an exercise price of $2.6, and 19,000 restricted stock units.
- Following these transactions, Karrels directly owns 177,593 shares of Macrogenics common stock and 113,000 employee stock options, and 19,998 restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports routine transactions by a company insider. The grant of options and RSUs is generally a positive sign, but the sale of shares to cover taxes is a common occurrence.
Positives
- The grant of stock options and RSUs to a key executive like the CFO suggests an incentive to align his interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's confidence in the company's prospects.
Stakeholder Impact
- The transactions reported in the Form 4 provide shareholders with information about the actions of a key company executive.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of grant for employee stock options and restricted stock units. |
| 02/07/2035 | Expiration date for employee stock options. |
| 02/08/2025 | Date of RSU vesting and stock disposal. |
| 02/11/2025 | Date of Form 4 filing. |
Keywords
Form 4, beneficial ownership, Macrogenics, MGNX, James Karrels, restricted stock units, employee stock options, securities, transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.